Singhvi Rahul
SEC insider (Form 3/4/5 filer). CIK 0001322731. Director at CODEXIS, INC. (CDXS) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 17, 2026. Located in REDWOOD CITY, CA.
Companies Singhvi Rahul has filed insider reports for
- CODEXIS, INC. (CDXS): Director
- Kairos Pharma, LTD. (KAPA): Director
Singhvi Rahul
CIK: 0001322731
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
